CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
复制标题
DOI:
10.3389/fimmu.2020.600000
复制
发表时间:
2020
影响因子:
7.3
通讯作者:
Sansom DM
中科院分区:
文献类型:
--
作者:
Halliday N;Williams C;Kennedy A;Waters E;Pesenacker AM;Soskic B;Hinze C;Hou TZ;Rowshanravan B;Janman D;Walker LSK;Sansom DM
CD80 and CD86 are expressed on antigen presenting cells and are required to engage their shared receptor, CD28, for the costimulation of CD4 T cells. It is unclear why two stimulatory ligands with overlapping roles have evolved. CD80 and CD86 also bind the regulatory molecule CTLA-4. We explored the role of CD80 and CD86 in the homeostasis and proliferation of CD4+FoxP3+ regulatory T cells (Treg), which constitutively express high levels of CTLA-4 yet are critically dependent upon CD28 signals. We observed that CD86 was the dominant ligand for Treg proliferation, survival, and maintenance of a regulatory phenotype, with higher expression of CTLA-4, ICOS, and OX40. We also explored whether CD80-CD28 interactions were specifically compromised by CTLA-4 and found that antibody blockade, clinical deficiency of CTLA-4 and CRISPR-Cas9 deletion of CTLA-4 all improved Treg survival following CD80 stimulation. Taken together, our data suggest that CD86 is the dominant costimulatory ligand for Treg homeostasis, despite its lower affinity for CD28, because CD80-CD28 interactions are selectively impaired by the high levels of CTLA-4. These data suggest a cell intrinsic role for CTLA-4 in regulating CD28 costimulation by direct competition for CD80, and indicate that that CD80 and CD86 have discrete roles in CD28 costimulation of CD4 T cells in the presence of high levels of CTLA-4.
登录
查看更多内容
DOI:
10.1084/jem.178.6.2185
发表时间:
1993-12-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Freeman GJ;Borriello F;Hodes RJ;Reiser H;Gribben JG;Ng JW;Kim J;Goldberg JM;Hathcock K;Laszlo G
通讯作者:
Laszlo G
DOI:
10.1084/jem.180.2.631
发表时间:
1994-08-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hathcock KS;Laszlo G;Pucillo C;Linsley P;Hodes RJ
通讯作者:
Hodes RJ
影响因子:
12.3
作者:
Collins, Mary;Ling, Vincent;Carreno, Beatriz M
通讯作者:
Carreno, Beatriz M
DOI:
10.1126/science.1202947
发表时间:
2011-04-29
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Qureshi OS;Zheng Y;Nakamura K;Attridge K;Manzotti C;Schmidt EM;Baker J;Jeffery LE;Kaur S;Briggs Z;Hou TZ;Futter CE;Anderson G;Walker LS;Sansom DM
通讯作者:
Sansom DM
DOI:
10.1084/jem.20062571
发表时间:
2007-09-03
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Anderson SM;Tomayko MM;Ahuja A;Haberman AM;Shlomchik MJ
通讯作者:
Shlomchik MJ